Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Reducing Vedolizumab Dosage for Patients with Inflammatory Bowel Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study on the Effectiveness and Safety of Obefazimod for Patients with Moderate to Severe Crohn’s Disease After Inadequate Response to Other Treatments

    Recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia France Germany Hungary Italy +5
  • Study on EXL01 for Preventing Crohn’s Disease Recurrence After Surgery in Patients

    Recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Long-term safety study of tulisokibart in adults with Crohn’s disease or ulcerative colitis

    Recruiting

    3 1
    Investigated Drugs:
    Czechia France Hungary Poland
  • Study on the Effectiveness and Safety of Vedolizumab and Upadacitinib in Adults with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium Croatia Czechia Denmark France +12
  • Study on Long-term Safety of Vedolizumab and Prednisone in Children with Ulcerative Colitis or Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Croatia Greece Hungary Italy Poland
  • Study of Mirikizumab for Children with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium France Italy The Netherlands Norway +3
  • Study on Upadacitinib for Children with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Bulgaria France Greece Italy Poland +1
  • Study on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1
    Investigated Drugs:
    Austria Belgium France Italy The Netherlands Norway +3
  • Study Comparing Azathioprine and Methotrexate with Adalimumab for Patients with Crohn’s Disease

    Recruiting

    3 1 1 1
    France